These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23522517)

  • 1. New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors.
    Nelson WL; Suls J
    J Pain Symptom Manage; 2013 Nov; 46(5):707-21. PubMed ID: 23522517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural correlates of chemotherapy-related cognitive impairment.
    Kaiser J; Bledowski C; Dietrich J
    Cortex; 2014 May; 54():33-50. PubMed ID: 24632463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information about chemotherapy-associated cognitive problems contributes to cognitive problems in cancer patients.
    Schagen SB; Das E; Vermeulen I
    Psychooncology; 2012 Oct; 21(10):1132-5. PubMed ID: 21769988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Schagen SB
    Crit Rev Oncol Hematol; 2013 Oct; 88(1):87-101. PubMed ID: 23768778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A meta-analysis of the effects of chemotherapy on cognition in patients with cancer.
    Hodgson KD; Hutchinson AD; Wilson CJ; Nettelbeck T
    Cancer Treat Rev; 2013 May; 39(3):297-304. PubMed ID: 23219452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment.
    Myers JS; Pierce J; Pazdernik T
    Oncol Nurs Forum; 2008 Nov; 35(6):916-20. PubMed ID: 18980922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives.
    Saykin AJ; Ahles TA; McDonald BC
    Semin Clin Neuropsychiatry; 2003 Oct; 8(4):201-16. PubMed ID: 14613048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating imaging findings in evaluating the post-chemotherapy brain.
    Pomykala KL; de Ruiter MB; Deprez S; McDonald BC; Silverman DH
    Brain Imaging Behav; 2013 Dec; 7(4):436-52. PubMed ID: 23828813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.
    Wefel JS; Vardy J; Ahles T; Schagen SB
    Lancet Oncol; 2011 Jul; 12(7):703-8. PubMed ID: 21354373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive dysfunctions in elderly cancer patients: a new challenge for oncologists.
    Lange M; Rigal O; Clarisse B; Giffard B; Sevin E; Barillet M; Eustache F; Joly F
    Cancer Treat Rev; 2014 Jul; 40(6):810-7. PubMed ID: 24713425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and cognitive impairment: treatment options.
    Fardell JE; Vardy J; Johnston IN; Winocur G
    Clin Pharmacol Ther; 2011 Sep; 90(3):366-76. PubMed ID: 21814191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive impairment associated with chemotherapy for cancer: report of a workshop.
    Tannock IF; Ahles TA; Ganz PA; Van Dam FS
    J Clin Oncol; 2004 Jun; 22(11):2233-9. PubMed ID: 15169812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-related cognitive dysfunction: current animal studies and future directions.
    Seigers R; Schagen SB; Van Tellingen O; Dietrich J
    Brain Imaging Behav; 2013 Dec; 7(4):453-9. PubMed ID: 23949877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The phenomenon of chemo brain.
    Staat K; Segatore M
    Clin J Oncol Nurs; 2005 Dec; 9(6):713-21. PubMed ID: 16381547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairments and cancer chemotherapy: translational research at a crossroads.
    Evenden J
    Life Sci; 2013 Oct; 93(17):589-95. PubMed ID: 23583572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
    Dutta V
    J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.